A Rose Is No Longer a Rose

This publication has 17 references indexed in Scilit:

• Comparative clinical pharmacology and pharmacokinetic interactions of aromatase inhibitors
  The Journal of Steroid Biochemistry and Molecular Biology, 2001
• A summary of second-line randomized studies of aromatase inhibitors
  The Journal of Steroid Biochemistry and Molecular Biology, 2001
• Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma
  Cancer, 2001
• Phase III, Multicenter, Double-Blind, Randomized Study of Letrozole, an Aromatase Inhibitor, for Advanced Breast Cancer Versus Megestrol Acetate
  Journal of Clinical Oncology, 2001
• Superior Efficacy of Letrozole Versus Tamoxifen as First-Line Therapy for Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Study of the International Letrozole Breast Cancer Group
  Journal of Clinical Oncology, 2001
• Activity of Exemestane in Metastatic Breast Cancer After Failure of Nonsteroidal Aromatase Inhibitors: A Phase II Trial
  Journal of Clinical Oncology, 2000
• Exemestane Is Superior to Megestrol Acetate After Tamoxifen Failure in Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Randomized Double-Blind Trial
  Journal of Clinical Oncology, 2000
• Meta‐analysis of trials comparing toremifene with tamoxifen and factors predicting outcome of antiestrogen therapy in postmenopausal women with breast cancer
  Breast Cancer Research and Treatment, 1999
• Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma
  Cancer, 1998
• Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.
  Journal of Clinical Oncology, 1998